Skip to main content
. 2012 Sep 4;20(12):2222–2233. doi: 10.1038/mt.2012.147

Figure 6.

Figure 6

AdF512v1 treatment of mice-harboring intraperiotoneally disseminated ovary cancer. (a) Protocol followed in the in vivo assays (b, c) evaluation of the antitumor effect of AdF512v1, Ad-F512 or vehicle [phosphate-buffered saline (PBS)] quantified as photons per experimental time point in two independent experiments. Error bars represent the mean ± SEM. Number of mice in (b): AdF512v1 (n = 5), Ad-F512 (n = 5), and PBS (n = 4); in (c): AdF512v1 (n = 6), and PBS (n = 5). P < 0.05, and **P < 0.01.